Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy.

نویسندگان

  • M Kanai
  • S Matsumoto
  • T Nishimura
  • Y Matsumura
  • E Hatano
  • A Mori
  • T Masui
  • Y Kawaguchi
  • E Nakamura
  • S Tada
  • T Kitano
  • H Ishiguro
  • K Yanagihara
  • T Chiba
چکیده

Gemcitabine treatment is commonly associated with skin rash, with a reported incidence of 7%–30% [1–3]; however, there exists only one prior report describing the management of gemcitabine-associated rash in the English-language literature [1]. When an extensive skin rash develops, both the patient and physician may experience anxiety about continuing gemcitabine treatment. For patients with a toxic drug-induced rash, continued administration of that drug may exacerbate the rash and put the patient at the risk of a more severe toxic event, such as toxic epidermal necrosis (TEN). From April 2008 to April 2009, we treated 107 patients with gemcitabine monotherapy and experienced four T a b le 1 . P at ie n t ch ar ac te ri st ic s

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Taxotere: Clinical Trials in Non-Small Cell Lung Cancer.

Cisplatin-based chemotherapy regimens of the 1980s have shown a small but significant impact on survival for patients with advanced non-small cell lung cancer (NSCLC). New agents, including docetaxel, have shown encouraging single-agent activity in this disease. This potent microtubule stabilizing agent was selected for clinical development based on its preclinical superiority to paclitaxel. Th...

متن کامل

Dermatose flagellée induite par bléomycine: un nouveau cas Clinique

We report the case of a 56-year old female patient with granulosa tumour of the ovary treated in our institute. She underwent complete resection followed by auxiliary chemotherapy according to BEP protocol (Bleomycine 30 Mg J1, J8 and J15, Etoposide 100mg/m J1-J5, Cisplatine 20 mg/m J1-J5). After her second cycle of BEP regimen, the patient had multiple skin linear hyperpigmentations at the lev...

متن کامل

Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study).

BACKGROUND Skin rash is an adverse event which might be associated with longer survival in patients treated with epidermal growth factor receptor tyrosine kinase inhibitors. The aim of this nonrandomised phase II clinical trial is to prospectively evaluate the relationship between skin rash and overall survival (OS) in advanced/metastatic pancreatic cancer treated with erlotinib plus gemcitabin...

متن کامل

Treatment of Postoperative Shivering with Dexamethasone: A Prospective Randomized Clinical Trial

Background: Postoperative shivering is an important and troublesome condition during recovery from general anesthesia.  Corticosteroids have been recommended to facilitate recovery and diminish shivering after cardiac surgery.  Previous studies recommended 0.6 mg/kg dexamethasone for reducing postoperative shivering in patients undergoing cardiac surgery.   Objective: To test this assertion, we...

متن کامل

Breast Cancer Associated with Dermatomyositis

Dermatomyositis (DM) is a rare idiopathic inflammatory myopathy with characteristic skin lesions. Case series have shown an association between dermatomyositis and malignancy. Malignancy has been found in 15-25% of the adult patients with dermatomyositis. A 50-year-old new case of breast cancer, was admitted with muscle weakness and inability to walk. Physical examination revealed fever, perior...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Annals of oncology : official journal of the European Society for Medical Oncology

دوره 21 1  شماره 

صفحات  -

تاریخ انتشار 2010